Meningeal Neoplasms
Showing 1 - 25 of 761
Meningeal Tumors, Leptomeningeal Disease Trial in Tübingen (No intervention)
Not yet recruiting
- Meningeal Neoplasms
- Leptomeningeal Disease
- No intervention
-
Tübingen, GermanyUniversity Hospital Tübingen, Neurooncology
Nov 16, 2023
Clinical, Radiological, Histologic and Molecular Features
Recruiting
- Meningeal Melanocytoma
- +3 more
-
Nancy, FranceNancy University Hospital Center
Jul 31, 2023
Patients With Leptomeningeal Metastases ((LM) Using CNSide
Recruiting
- Leptomeningeal Metastasis
- +4 more
- CNSide
-
Los Angeles, CaliforniaValkyrie Clinical Trials
Sep 7, 2022
CNS/Leptomeningeal Tumors Trial in New York (131I-omburtamab)
Available
- Central Nervous System/Leptomeningeal Neoplasms
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 15, 2022
Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)
Recruiting
- Leptomeningeal Disease
- +2 more
- Dendritic Cell Vaccine
-
Tampa, FloridaMoffitt Cancer Center
Apr 11, 2023
Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)
Active, not recruiting
- Leptomeningeal Metastases
- Leptomeningeal Disease
- Avelumab
- Whole Brain Radiotherapy
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 19, 2022
HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease Trial in Tampa, Evanston (Radiation Therapy,
Recruiting
- HER2-positive Breast Cancer
- +2 more
- Radiation Therapy
- +2 more
-
Tampa, Florida
- +1 more
Dec 30, 2022
Leptomeningeal Disease Trial in Germany (Nivolumab [Opdivo])
Recruiting
- Leptomeningeal Disease
- Nivolumab [Opdivo]
-
Freiburg, Germany
- +6 more
Nov 2, 2022
Patient Perceptions Around Quality of Care Through Telemedicine
Recruiting
- Central Nervous System Neoplasm
- +3 more
- Electronic Health Record Review
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Nov 19, 2021
Glioma, Brain Metastases Trial in Shanghai (Autologous progenitor expansion -T, pemetrexed)
Recruiting
- Glioma
- Brain Metastases
- Autologous progenitor expansion -T
- pemetrexed
-
Shanghai, Shanghai, ChinaFudan University Pudong Medical Center
Jul 12, 2022
Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)
Not yet recruiting
- Breast Cancer Metastatic
- Leptomeningeal Metastasis
- Tucatinib Oral Tablet
- +2 more
- (no location specified)
Mar 23, 2023
Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States
Recruiting
- Leptomeningeal Neoplasm
- +6 more
- Sapanisertib
- Telaglenastat Hydrochloride
-
Duarte, California
- +6 more
Dec 29, 2022
Acral Lentiginous Melanoma, CNS Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Houston (Nivolumab)
Active, not recruiting
- Acral Lentiginous Melanoma
- +9 more
- Biospecimen Collection
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 31, 2023
Breast Cancer Female, Leptomeningeal Metastases Trial in Charlottesville (HER2 BATs)
Terminated
- Breast Cancer Female
- Leptomeningeal Metastases
- HER2 BATs
-
Charlottesville, VirginiaUniversity of Virginia
Dec 15, 2022
Patients With Leptomeningeal Disease Trial in Baltimore (Pembrolizumab)
Terminated
- Patients With Leptomeningeal Disease
-
Baltimore, MarylandJohns Hopkins Sidney Kimmel Comprehensive Cancer Center
Jan 6, 2021
Dalpiciclib Combined With Third-generation EGFR-TKI in EGFR
Not yet recruiting
- Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology
- +6 more
- (no location specified)
Aug 9, 2022
NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591 Tablets)
Recruiting
- NSCLC
- +3 more
- TY-9591 Tablets
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospitial,Chinese Academy of Medic
May 14, 2022
NSCLC, Brain Metastases, Leptomeningeal Metastasis Trial in Zhengzhou (almonertinib, LM-first line treatment, LM-second line
Recruiting
- NSCLC
- +2 more
- almonertinib
- +2 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Aug 25, 2021
Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Radiotherapy)
Recruiting
- Leptomeningeal Metastasis
- Pemetrexed
- Radiotherapy
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jun 8, 2022
Brain Metastases, Leptomeningeal Metastasis Trial in United States (GDC-0084, whole brain radiation therapy radiation)
Recruiting
- Brain Metastases
- Leptomeningeal Metastasis
- GDC-0084
- whole brain radiation therapy radiation
-
Miami, Florida
- +9 more
Jan 3, 2023
NSCLC, Leptomeningeal Metastases, Brain Metastases Trial in United States (Tesevatinib)
Completed
- Non-Small Cell Lung Cancer
- +2 more
-
Beverly Hills, California
- +6 more
Mar 7, 2022
Leptomeningeal Metastasis, Lung Cancer Trial in Hebei (Nimotuzumab)
Recruiting
- Leptomeningeal Metastasis
- Lung Cancer
-
Hebei, Shijiazhuang/hebei, China
- +1 more
Apr 18, 2021
Breast Cancer, Leptomeningeal Metastasis Trial in Lille (Cerebrospinal fluid and blood sample collection at the initial
Withdrawn
- Breast Cancer
- Leptomeningeal Metastasis
- Cerebrospinal fluid and blood sample collection at the initial diagnostic assessment
- +2 more
-
Lille, Hauts-de- France, France
- +1 more
Oct 5, 2021
Malignant Meningeal Tumors Trial in United States (Intrathecal Mafosfamide)
Completed
- Malignant Meningeal Neoplasms
- Intrathecal Mafosfamide
-
Los Angeles, California
- +9 more
Mar 2, 2020